December 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreOctober 10, 2025
Market insights predict the global Latin America pharmaceutical industry will increase from USD 91.85 billion in 2024 to USD 172.71 billion by 2034, achieving a CAGR of 6.52%. The market is expanding due to the rising prevalence of chronic diseases, increasing healthcare expenditure, and growing demand for innovative therapies. In Latin America, Br...
October 08, 2025
Market insights predict the North America pharmaceutical industry will increase from USD 601.17 billion in 2024 to USD 1043.48 billion by 2034, achieving a CAGR of 5.67%. The continued innovations and high healthcare spending in potential pharmaceutical areas related to diabetes, obesity, oncology, cardiovascular diseases, and neurological disorder...
October 08, 2025
Market insights predict, the Middle East and Africa pharmaceutical industry is expected to grow from USD 75.15 billion in 2024 to USD 141.3 billion by 2034, driven by a CAGR of 6.52%. This market is rising due to increasing chronic disease prevalence, growing healthcare investments, expanding local manufacturing, and improved access through digital...
October 07, 2025
Market insights predict, the APAC pharmaceutical industry is expected to grow from USD 434.19 billion in 2024 to USD 855.68 billion by 2034, driven by a CAGR of 7.02%. The rising prevalence of chronic disorders and the increasing need for personalized medicines bolster market growth. China’s dominance in the market is attributed to the strong...
October 03, 2025
According to forecasts, the global meloxicam market will grow from USD 7.62 billion in 2024 to USD 12.23 billion by 2034, with an expected CAGR of 4.84%. The market is growing due to the increasing prevalence of inflammatory and pain-related conditions, along with rising demand for safe, effective NSAID therapies. In North America, the market domin...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com